Interestingly, a recent study found that H2AY is specifically up-regulated in Huntington’s disease (HD) postmortem brain and lymphoid cells, and the levels of this mRNA are normalized by treatment of HD patients in human clinical studies with the HDAC inhibitors sodium butyrate and sodium phenylbutyrate (44). Here, HDAC9 is linked to Huntington disease.